In this episode, Mike Burke, AGG Corporate partner and co-chair of the firm’s International practice, is joined by Gabe Scannapieco, AGG Litigation & Dispute Resolution partner, to discuss enforcement trends affecting foreign pharmaceutical and medical device manufacturers. Mike and Gabe explore the increasing regulatory scrutiny on overseas facilities, the role of U.S. agencies in compliance and inspections, and practical steps companies can take to mitigate legal and operational risks when entering the U.S. market.
Press CTRL+C to copy embed code to clipboard